BELFAST, Ireland, Jan. 23, 2025 (GLOBE NEWSWIRE) — The Ireland based software company StormHarvester, has today announced an investment of $10.2M, which will propel the growth of the company and see its workforce double in size over the next three years. The market-leading company, which developed an automated water management software platform that helps wastewater […]
(NYSE:ITGR), PLANO, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full year 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, February 20, 2025. Following the release, Integer management will host
BOSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) — Is retail ready for the always-on consumer? Salsify, the platform empowering brand manufacturers, distributors, and retailers to win on the digital shelf, reveals in its 2025 Consumer Research Report that 69% of shoppers make purchases while multitasking–scrolling TikTok, watching Netflix, or browsing YouTube. Economic strains and emerging technologies
LONDON, Jan. 23, 2025 (GLOBE NEWSWIRE) — Spur Therapeutics today announced that it will share updated clinical data from its Phase 1/2 GALILEO-1 trial of FLT201, its adeno-associated virus (AAV) gene therapy candidate for Gaucher disease type 1, in platform and poster presentations at the 21st Annual WORLDSymposiumTM being held February 3-7, 2025, in San
(Copenhagen:GN.CO), Jabra introduces an over-the-air update to the leading Speak2 75 professional speakerphone The Speak2 75s new firmware update allows two Speak2 75 speakerphones to link, providing expanded meeting room audio coverage and increased flexibility Once connected, the Bluetooth linking is permanent, empowering users with a great plug-and-play experience The Speak2 75s automatically switch between
(NASDAQ:MBX), CARMEL, Ind., Jan. 23, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, will present at, and participate in, the following
(NASDAQ:RUN), SAN FRANCISCO, Jan. 23, 2025 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN) today announced that it will issue its fourth quarter and full-year 2024 earnings report after the market closes on Thursday, February 27, 2025. A conference call has been scheduled to discuss these earnings results at 1:30 p.m. Pacific Time. The conference call can
(NasdaqGM:FMBH), MATTOON, Ill., Jan. 23, 2025 (GLOBE NEWSWIRE) — First Mid Bancshares, Inc. (NASDAQ: FMBH) (the “Company”) today announced its financial results for the quarter ended December 31, 2024. Highlights Net income of $19.2 million, or $0.80 diluted EPS Adjusted net income (non-GAAP) of $20.9 million, or $0.87 diluted EPS Loan growth and interest expense
(Madrid:ORY.MC),(Boerse Stuttgart – Freiverkehr: ORN), Exploring the combination with azacitidine Study led by Medical College of Wisconsin MADRID and CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the first
(NASDAQ:LSTA), Data corroborate previously reported preclinical data demonstrating certepetide's ability to enhance the effectiveness of immunotherapy Preliminary results to be presented at the 2025 ASCO Gastrointestinal Cancers Symposium BASKING RIDGE, N.J. and SUBIACO, Australia, Jan. 23, 2025 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative